CUSIP 64136E102COMNEUPQ4 2025
12 filings · latest Feb 6, 2026
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Lynx1 Capital Management LP | 875.2K | $3.40M |
| 2 | Shay Capital LLC | 169.1K | $655.9K |
| 3 | Advisorshares Investments LLC | 134.2K | $520.7K |
| 4 | Diadema Partners LP | 50.0K | $194.0K |
| 5 | Ikarian Capital, LLC | 47.4K | $184.1K |
| 6 | Adar1 Capital Management, LLC | 30.0K | $116.4K |
| 7 | Vanguard Group Inc | 20.9K | $81.3K |
| 8 | Geode Capital Management, LLC | 17.3K | $67.1K |
| 9 |
| 4 | Nov 28, 2025 | Lynx1 Capital Management LP | 13D/A | 16.3% | — | SEC |
| 5 | Nov 18, 2025 | Lynx1 Capital Management LP | 13D/A | 16.3% | — | SEC |
| 6 | Nov 10, 2025 | Lynx1 Capital Management LP | 13D/A | 26.5% | — | SEC |
| 7 | Nov 5, 2025 | Coastlands Capital LP | 13G | 5.1% | — | SEC |
| 8 | Oct 31, 2025 | Baselake Partners, LP | 13G | 9.4% | 222.2K | SEC |
| 9 | Oct 31, 2025 | Shay Capital LLC | 13G | 11.0% | 171.6K | SEC |
| 10 | Oct 23, 2025 | Lynx1 Capital Management LP | 13D | 37.1% | — | SEC |
See the full Schedule 13D/13G history for Neuphoria Therapeutics Inc.
Unlock full history| Jane Street Group, LLC |
| 16.6K |
| $64.4K |
| 10 | Bridgeway Capital Management, LLC | 14.8K | $57.2K |